Defining Outcomes for -cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders Workshop

Michael R Rickels; Peter G Stock; Eelco JP de Koning; Lorenzo Piemonti; Johann Pratschke; Rodolfo Alejandro; Melena D Bellin; Thierry Berney; Pratik Choudhary; Paul R Johnson; Raja Kandaswamy; Thomas WH Kay; Bart Keymeulen; Yogish C Kudva; Esther Latres; Robert M Langer; Roger Lehmann; Barbara Ludwig; James F Markmann; Marjana Marinac; Jon S Odorico; Francois Pattou; Peter A Senior; James AM Shaw; Marie-Christine Vantyghem; Steven White

Journal article

Defining Outcomes for -cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders Workshop

Michael R Rickels, Peter G Stock, Eelco JP de Koning, Lorenzo Piemonti, Johann Pratschke, Rodolfo Alejandro, Melena D Bellin, Thierry Berney, Pratik Choudhary, Paul R Johnson, Raja Kandaswamy, Thomas WH Kay, Bart Keymeulen, Yogish C Kudva, Esther Latres, Robert M Langer, Roger Lehmann, Barbara Ludwig, James F Markmann, Marjana Marinac Show all

Transplantation | LIPPINCOTT WILLIAMS & WILKINS | Published : 2018

DOI: 10.1097/TP.0000000000002158

University of Melbourne Researchers

Thomas Kay Author Medicine - St Vincent's Hospital

Grants

Awarded by U.S. Public Health Services

Awarded by NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES

Funding Acknowledgements

The workshop was supported in part by educational grants received from The Transplantation Society and JDRF International. M.R.R. is supported in part by U.S. Public Health Services research grants R01 DK091331, R01 DK97830, and U01 DK070430. Y.C.K. is supported in part by U.S. Public Health Services research grant UC4 DK108483.